 MENLO PARK, Calif., June 11, 2021 GLOBE NEWSWIRE -- Pacific Biosciences of California, Inc. NASDAQ: PACB Pacific Biosciences or the Company, a leading provider of high-quality sequencing platforms, today announced that the Compensation Committee of the Companys Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of Pacific Biosciences common stock, and restricted stock units RSUs covering 40,000 shares of Pacific Biosciences common stock, to a recently hired employee under the Pacific Biosciences 2020 Inducement Equity Incentive Plan the 2020 Inducement Plan effective on June 7, 2021. 